Skip to content
Pharma Observatory a Scientist.com platform

Condition (MeSH)

Femoral Fractures, Distal

ClinicalTrials.gov lists 30 trials for Femoral Fractures, Distal or a narrower condition beneath it.

MeSH D000092524 Wounds and Injuries C26
Email me this page as a PDF

Search trials, drugs, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Phase 1/2 Phase 1/2 1 Phase 4 Phase 4 1 Not applicable Not applicable 19 Observational Observational 9 Phase 1/2 Phase 1/2 1 Phase 4 Phase 4 1 Not applicable Not applicable 19 Observational Observational 9

Trials per phase

30 of the 30 trials are tagged with Femoral Fractures, Distal itself; the rest are tagged with a narrower condition beneath it.

Get the Femoral Fractures, Distal report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

When did Femoral Fractures, Distal trials start? (17)

Shown in this order: most recent first, 1990 onwards. 2026 is partial: trials registered with a 2026 start date so far, not a full year.

Trials over time, by phase

  • Phase 4
  • Not applicable
  • Observational

Top of scale: 4

2006: 1 trials (Observational 1) 2010: 1 trials (Not applicable 1) 2011: 1 trials (Observational 1) 2012: 3 trials (Observational 2, Phase 4 1) 2013: 1 trials (Not applicable 1) 2014: 1 trials (Not applicable 1) 2015: 1 trials (Observational 1) 2016: 2 trials (Observational 1, Not applicable 1) 2018: 1 trials (Not applicable 1) 2019: 3 trials (Observational 2, Not applicable 1) 2020: 1 trials (Not applicable 1) 2021: 1 trials (Not applicable 1) 2022: 1 trials (Not applicable 1) 2023: 2 trials (Not applicable 2) 2024: 3 trials (Observational 1, Not applicable 2) 2025: 4 trials (Not applicable 4)

Trials registered with a start date in each year, 1990 onward, stacked by phase (complete years only; the current partial year is in the table's notes). The table below lists the same counts, most recent years first.

Trials started per year
Year Trials started
2026 (partial year) 2
2025 4
2024 3
2023 2
2022 1
2021 1
2020 1
2019 3
2018 1
2016 2

No forecast is made for this condition: it averages 2.6 trial starts a year over the five years to September, under the 5 a year the method needs.

Prediction, not a registry value: median of 36 months from start to primary completion across 8 trials still running at the 2026-10-09 snapshot; registered median of 44 months across 11 trials with a primary completion typed Actual. Source: ClinicalTrials.gov / AACT (CTTI), public domain.

What phase are Femoral Fractures, Distal trials in? (4)

Shown in this order: phase order.

Show the trials by phase as a table
Trials by phase
Phase Trials
Phase 1/2 1
Phase 4 1
Not applicable 19
Observational 9

How many Femoral Fractures, Distal trials are recruiting? (8)

Shown in this order: the order a trial moves through, from not yet recruiting to unknown.

Trials by recruitment status
Status Trials
Not yet recruiting 1
Recruiting 9
Enrolling by invitation 1
Active, not recruiting 2
Completed 8

Status as registered on ClinicalTrials.gov. Each trial is counted once.

Which lead sponsors run the most Femoral Fractures, Distal trials? (2)

Shown in this order: most trials first. Lead sponsors the registry classes as industry, NIH, US federal, other government or network. A hospital or university the registry files as government can appear here. Sponsors it classes as academic or other are shown on the full page, because that class cannot separate an institution from a named investigator.

Lead sponsors
Sponsor Trials
41medical AG 1
Florida Orthopaedic Institute 1

Which publications cover Femoral Fractures, Distal? (1)

Shown in this order: major-topic papers first, then newest, then most linked to trials.

Not on this page

Not measured: delivery record.

Checked, with nothing recorded for this condition: drugs tested, serious adverse events in this condition's trials, prevalence, rare-disease identity, and sub-conditions in mesh.

Browse all condition evidence pages